S1P, a bioactive sphingolipid metabolite being produced by one of two sphingosine kinase isoforms (SPHK1 or SPHK2), can be released through transporters into the tumor microenvironment to influence tumor cells as well as immune cells, contributing to carcinogenesis [14]. Here, SPHK1 is linked to neoplasm.